National Comprehensive Cancer Network 2025 Annual Conference
The National Comprehensive Cancer Network (NCCN) 2025 Annual Conference, taking place March 28-30, in Orlando, Florida, focuses on updates to NCCN Guidelines® across cancer types. The conference also features information on screening, prevention, supportive care, data collection and utilization, care team collaboration, and more.
Researchers analyzed clinical outcomes because hematopoietic SCT is becoming more a more accessible and utilized treatment.
Research presented at the NCCN Annual Conference illuminated patient experiences with tyrosine kinase inhibitors.
Researchers assessed the cost effectiveness of ibrutinib, acalabrutinib, and zanubrutinib in multiple treatment settings.
A study presented at the NCCN Annual Conference shed light on the perspectives of patients and healthcare professionals.
The presentation focused on how ambulatory care models shape patient outcomes, nursing roles, and continuing education.
Researchers investigated underlying drivers of HRQOL degradation in CLL, including muscle weakness and fatigue.
The program will feature nursing perspectives on patient access, finances in cancer care, and holistic self-care for nurses.
Advertisement